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ABSTRACT  
          A high performance liquid chromatography (HPLC) and 
ultraviolet spectroscopic (UV) methods were developed and 
validated for the quantitative estimation of doxofylline (DF) in 
pharmaceutical dosage forms. HPLC was carried out using reverse-
phase technique on RP-8 column with a mobile phase composed of 
0.05M phosphate buffer pH 6 and acetonitrile (60:40, v/v). The 
mobile phase was pumped at a flow rate of 1mL/min, and 
detection was made at 230nm with PDA detector. UV method was 
performed with λ max at 270nm with apparent molar absorptive of 
0.878x103L mol-1 cm-1. Both the methods showed good linearity, 
recovery and precision. No spectral or chromatographic 
interferences from the tablet excipients were found in UV and HPLC 
methods. The various parameters such as linearity, precision, 
accuracy, specificity, and robustness, limit of detection and limit of 
quantization were studied according to ICH guidelines. Statistical 
analysis was done by student’s t-test and F-test, which showed no 
significant difference between the results of both methods. So the 
proposed methods could be applicable for routine analysis of DF 
and monitoring of the quality of marketed drugs.  
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Doxofylline (DF) is chemically 7-(1, 3-
Dioxolan-2-yl-methyl)-3, 7-dihydro-1, 3-
dimethyl-1H-purine-2, 6-dione (Figure 1) 
belongs to the class of antiasthmatic/ 
bronchodilators. It is a new generation of 
methyl xanthine derivative. Literature survey 
revealed that doxofylline was estimated by few 
RP-HPLC methods in dosage forms (Akilesh et 
al., 2011; Ashu et al., 2010 and Venkatesan et al., 
2010) and in biological samples (Gannu et al., 
2007).  Some spectrophotometric methods also 
have been reported for estimation of DF 
(Kamila et al., 2007; Sagar et al., 2011; and 
kumar et al., 2011). Joshi et al. (2010) has been 
reported for the development of UV and 
HPLC methods for estimation of doxofylline in 
pharmaceutical formulation. The huge amounts 
of  costlier   solvents   were   used as  mobile  phase  
 
 
solvent system and time of analysis also more 
in some reported methods.  
The aim of the present work was to 
develop simple, fast and reliable isocratic RP-
HPLC, UV methods for the determination of 
DF in pharmaceutical dosage forms by using 
less cost solvents. The results of analysis using 
the UV and RP-HPLC method were found to 
be satisfactory, such that the proposed methods 
can be utilized for routine analysis of drug. 
 
 
Figure 1. Chemical structure 
of doxofylline 
Ethiraj T and Revathi R 
 
Volume 24 Issue 1 (2013) 15 
METHODOLOGY 
Chemicals 
HPLC grade acetonitrile and potassium 
dihydrogen phosphate (AR grade) were 
purchased from Rankem Fine Chemicals Ltd. 
Water (HPLC grade) was obtained from a Milli-
Q water purification system (Millipore, Milford, 
USA). Acetone and ortho- phosphoric acid 
were purchased from S.D.Fine Chemicals Ltd. 
DF was kindly supplied by Fourrt’s India, 
Chennai. Pharmaceutical dosage forms 
(T.Doxobid, T.Synasma) containing 400mg of 
DF were obtained commercially. 
 
Instrumentation and analytical condition 
HPLC chromatographic separation was 
performed on a Shimadzu Prominence Liquid 
Chromatographic System equipped with a LC-
10AT-VP solvent delivery system (pump), SPD 
M-10 AVP photo diode array detector and 
rheodyne injector with LC solution software 
version 1.2. The HPLC was carried out at a flow 
rate of 1mL/min using a mobile phase 
consisted of 0.05M phosphate buffer pH 6: 
acetonitrile (60:40, v/v) and detection was made 
at 230nm. The mobile phase was prepared daily, 
filtered through a 0.45µm membrane filter          
and sonicated before being used for analysis. 
Intersil C8 column (5µm, 4.6×250mm) was 
used for separation. UV method was performed 
on UV-Visible spectrophotometer (UV-2201, 
Systronics) with the λ max at 270nm using 
10mm matched quartz cells. 
 
Standard solution 
For HPLC: Accurately weighed 100mg of 
DF reference standard was transferred to 
100mL volumetric flask, dissolved and              
made         up to the mark with mobile phase 
(1mg/mL concentration). The concentrations 
of 5-50µg/mL were prepared individually            
from the above stock solution using mobile 
phase. 
UV: Accurately weighed 100mg of DF 
reference standard was transferred to 100mL 
volumetric flask and dissolved in 10mL of 
acetone. Then, the volume was made up to the 
mark with 15% phosphoric acid to get               
final concentration of 1mg/mL. From this stock 
solution, the concentration ranges from  5-
30µg/mL were made in 10 mL volumetric flasks 
and volume was adjusted with distilled water. 
Sample solution 
HPLC: Twenty tablets of each brand, 
each containing 400 mg of DF were weighed 
and finely powdered; a quantity of powder 
equivalent to 100mg of DF was transferred to a 
100mL flask and made the volume up to the 
mark with mobile phase. It was kept in 
ultrasonication for 45 minute and filtered 
through 0.45µm membrane filter. Furthermore, 
it was diluted with same to get 10µg/mL 
concentrations. 
UV: For estimation of DF in tablet 
dosage formulations, twenty tablets of each 
brands were weighed and triturated to fine 
powder. Tablet powder equivalent to 100mg of 
DF was weighed and dissolved in 10mL 
acetone and further diluted with 15% 
phosphoric acid. It was kept for ultrasonication 
for 45min and filtered through Whatmann filter 
paper No.41 to get the stock solution of 
1mg/mL. Then, the solution was diluted with 




The objective of the method validation is 
to demonstrate that the method is suitable for 
its intended purpose, as it is stated in ICH 
guidelines (ICH guidelines, 2005). The method 
was validated for linearity, precision, accuracy 
and system suitability. Student’s t-test and F-
test were used to verify the validity of the 
methods. 
Linearity: The calibration curve was 
obtained with various concentrations of 
standard solution, as 5-50µg/mL for HPLC 
method and 5-30µg/mL for UV method, 
respectively. The solutions were prepared in 
triplicate and linearity was evaluated by linear 
regression analysis. LOD and LOQ were 
determined on the basis of slope and intercept 
values from regression equation. 
Precision: The precision of the assay was 
studied with respect to both repeatability and 
intermediate precision. Repeatability was 
calculated from three replicate injections of 
freshly prepared DF solution in the same 
equipment at a concentration of 20µg/mL on 
the same day. The experiment was repeated by 
assaying freshly prepared solution at the same 
concentration additionally on two consecutive 
days to determine intermediate precision. 
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Accuracy: Percentage recovery was 
analyzed by adding reference drug of DF at 
three different levels to the powdered drug 
product using three preparations at each level. 
The results were expressed as the percentage of 
DF recovered in the sample and %RSD. 
Specificity: Specificity of the HPLC 
method was assessed by comparing the 
chromatograms obtained from standard and 
sample preparations with those obtained from 
excipients which take part in the commercial 
tablet preparation. 
Robustness: the robustness of the HPLC 
method was determined by analysis of samples 
under various conditions like changes in the pH 
(5.8-6.2), changes in the percentage of organic 
phase (±10%) in the mobile phase and changes 
in the flow rate (0.9mL/min-1.1 mL/min). The 
effect of retention time and system suitability 
parameters was observed. For UV, the drug 
content was analysed under the experimental 
variables like changes in the concentration of 
the reagent and stability of the sample solution.  
 
 
Figure 2. Chromatogram for doxofylline 
 
 


















Figure 3. Calibration graph for HPLC method 
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RESULTS AND DISCUSSION 
HPLC method: A reversed phase HPLC 
method was developed to analyze DF in 
pharmaceutical preparation as a suitable 
method. The chromatographic conditions were 
adjusted in order to provide a better result for 
assay. The mobile phase (0.05M phosphate 
buffer pH 6 and acetonitrile (60:40,v/v)) was 
selected by taking into account some peak 
parameters like tailing factor, number of 
theoretical plates, run time, easy of preparation 
and cost. A typical chromatogram (Figure 2) 
was obtained with retention time of 3.107min 
which showed a rapid determination of drug 
for frequent analysis. In this proposed          
method,  the   peak   was   eluted  with  a tailing  
factor (T) 1.55 and number of theoretical  
plates (N) 4003. From the calibration curve 
(Figure 3), DF showed good linearity in the 
range of 5-50µg/mL with regression equation 
of y=587.71x-119.31 and correlation coefficient 
of r= 0.9995, indicating a high sensitivity of the 
method (Table I). The precision of the     
method was ascertained by repeatability (Intra-
day) and intermediate precision (Inter-day). The 
results of % purity and % RSD were tabulated 
in table II showing good precision. The 
recovery of the drug was analyzed by adding 
different levels (10%, 20% and 30%) of 
standard drug to the predetermined tablet 
powder. The results of % RSD, SE were 
showed in table III. 
 
 





Figure 5. UV spectrum for doxofylline (20 µg/mL). 
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There was no significant change in the 
system suitability factors of DF when the 
organic composition, flow rate and column 
temperature were changed. The low values of 
the % RSD indicated that the method was 
robust (Table IV). 
UV method: The spectrum of DF 
standard solution with concentrations of 15, 20 
and 30µg/mL (Figure 4-6) showed intense 
absorbance peak with λ max at 270nm. The 
good linearity (Figure 7) was obtained on 
standard solutions of DF over the 
concentration range of 5-30µg/mL. The 
precision of the method was assessed with % 
RSD values of 0.1680 for repeatability             
and 0.1126 for intermediate precision which 
were found for three replicates at a 
concentration of 20µg/mL (Table II). Accuracy 
of the method was done as per HPLC       
method and the mean percentage content 
obtained was between 99.60% and 100.46% 
with 95% confidence interval of 97.964 and 
102.72 (Table III). 
Robustness of the method was assessed 
by evaluating the influence of small variations 
of experimental variables like changes in the 
concentration of the reagent and stability of the 
sample solution on the analytical performance. 
The small variations in any of the variables did 
not significantly affect the results. This 
provided an indication for the reliability of the 




Figure 6. UV spectrum for doxofylline (30µg/mL) 
 









 Figure 7. Calibration graph for UV method 
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Table I.  Results for linearity study 
 
Parameters HPLC method UV method 




Standard Error on Slope 
Confidence Limit of Slope  
Intercept 
Standard Error on Intercept 
Confidence Limit of  Intercept 
Correlation Co-efficient 






577.31 to 598.12 
-119.31 
139.95 








0.03644 to 0.04037 
-0.009600 
0.01376 




µg/mL = Micro gram per Milli litre, LOD = Limit of Detection,  
LOQ = Limit of Quantitation 
 
 
Table II. Results for precision study data 
Methods  Precision parameters Amount found 
(mg) 




Repeatability 400.66 100.16 0.1212  
HPLC Intermediate Precision 400.74 100.18 0.1046 
Repeatability 401.29 100.32 0.1680  
UV Intermediate Precision 400.71 100.17 0.1126 
 
 
Table III.  Results for recovery study data 


























































































*(n=3), % RSD = Percentage Relative Standard Deviation, S.E = Standard Error, 95 % CI = 95 Percent 
Confidence Interval 
 
Development of Doxofylline Analysis  
 
Volume 24 Issue 1 (2013) 20 
          Comparison and application of the 
methods to the analysis of tablets: From the 
validation results, the above developed 
methods were suitable for routine quality 
control analysis of DF in marketed 
formulations. They were applied for two 
different brands of DF and the results were 
statistically compared (Table V). In the t-test 
and F-tests, no significant differences were 
found between the calculated and theoretical 
values of both methods at 95% confidence 
interval. From this report, it was evident that 
the proposed UV and HPLC methods were 




The above proposed methods are very 
simple, precise and sensitive. It was concluded 
that, the spectroscopic method requires only 
wavelength scan, while the HPLC method was 
less time consuming method (within 4 min). 
Further more, the developed spectroscopic and 
liquid chromatography methods are cheaper 
when  compared   to  other  reported  methods.  
No need of any extraction procedure to 
separate the active constituents from 
formulation and time of analysis was very less. 
Hence, the above said methods can be utilized 
for routine analysis of DF in bulk and 
pharmaceutical dosage forms.   
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Conc of reagent 
(phosphoric acid)  
12 % 
18 % 




Stability of sample 
solution 
After 6 h 
After 12 h 
-  100.48 
100.98 
 
% content = Percentage Drug Content 
 
Table V. Results for statistical comparison on UV and HPLC methods  
 














a,b = Limits of 95 % confidence Interval 
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